Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines
Journal of the European Academy of Dermatology and Venereology | Sep 05, 2021
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: Results from the JADE REGIMEN phase 3 trial
Journal of the American Academy of Dermatology | Aug 20, 2021
Most read this week